252 related articles for article (PubMed ID: 35841069)
1. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis.
Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z
Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.
Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y
Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis.
Gou Y; Li X; Li P; Zhang H; Xu T; Wang H; Wang B; Ma X; Jiang X; Zhang Z
Hum Reprod; 2019 Apr; 34(4):646-658. PubMed ID: 30838396
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
[TBL] [Abstract][Full Text] [Related]
5. The extracellular vesicular pseudogene LGMNP1 induces M2-like macrophage polarization by upregulating LGMN and serves as a novel promising predictive biomarker for ovarian endometriosis recurrence.
Sun SG; Guo JJ; Qu XY; Tang XY; Lin YY; Hua KQ; Qiu JJ
Hum Reprod; 2022 Mar; 37(3):447-465. PubMed ID: 34893848
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis.
Mei J; Xie XX; Li MQ; Wei CY; Jin LP; Li DJ; Zhu XY
Int J Clin Exp Pathol; 2014; 7(6):2743-57. PubMed ID: 25031694
[TBL] [Abstract][Full Text] [Related]
8. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
[TBL] [Abstract][Full Text] [Related]
9. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
10. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
11. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
12. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
[TBL] [Abstract][Full Text] [Related]
13. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
14. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
15. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
16. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
17. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
[TBL] [Abstract][Full Text] [Related]
19. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
20. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
